Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Garcia

Showing results (331-340 of 455) with videos related to

Pageof 46
Sort By:
Pacing and Clinical Electrophysiology : PACE|December 6, 2023
Feasibility and safety of left bundle branch area pacing in cardiac amyloidosis. A single center experienceChinh Pham-Trung, Darwin Veloza-Urrea, Melodie Segura-Domínguez, et al.
Journal of the American College of Cardiology|August 27, 2025
Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Exploratory Insights From the ODYSSEY-HCM TrialMilind Y Desai, Yuichiro Okushi, Shada Jadam, et al.
Journal of Hepatology|June 20, 2014
ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitisRaquel Fucho, Laura Martínez, Anna Baulies, et al.
Orphanet Journal of Rare Diseases|November 10, 2023
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Luca Gentile, Teresa Coelho, Angela Dispenzieri, et al.
Circulation|October 1, 2019
Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3βLaura Padrón-Barthe, María Villalba-Orero, Jesús M Gómez-Salinero, et al.
Heart (British Cardiac Society)|October 28, 2018
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysisConstantinos O'Mahony, Mohammed Majid Akhtar, Zacharias Anastasiou, et al.
Journal of the American College of Cardiology|March 12, 2025
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid CardiomyopathyDaniel P Judge, Kevin M Alexander, Francesco Cappelli, et al.
European Heart Journal|November 6, 2020
Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differencesJob A J Verdonschot, Marco Merlo, Fernando Dominguez, et al.
ACS Sensors|December 12, 2018
Implanted Nanosensors in Marine Organisms for Physiological Biologging: Design, Feasibility, and Species VariabilityMichael A Lee, Freddy T Nguyen, Kathleen Scott, et al.
Acta Obstetricia Et Gynecologica Scandinavica|August 22, 2024
Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trialMarta Ricart, Erika Bonacina, Pablo Garcia-Manau, et al.
Pageof 46

Showing results (331-340 of 455) with videos related to

Sort By:
Pageof 46
Pacing and Clinical Electrophysiology : PACE|December 6, 2023
Feasibility and safety of left bundle branch area pacing in cardiac amyloidosis. A single center experienceChinh Pham-Trung, Darwin Veloza-Urrea, Melodie Segura-Domínguez, et al.
Journal of the American College of Cardiology|August 27, 2025
Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Exploratory Insights From the ODYSSEY-HCM TrialMilind Y Desai, Yuichiro Okushi, Shada Jadam, et al.
Journal of Hepatology|June 20, 2014
ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitisRaquel Fucho, Laura Martínez, Anna Baulies, et al.
Orphanet Journal of Rare Diseases|November 10, 2023
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Luca Gentile, Teresa Coelho, Angela Dispenzieri, et al.
Circulation|October 1, 2019
Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3βLaura Padrón-Barthe, María Villalba-Orero, Jesús M Gómez-Salinero, et al.
Heart (British Cardiac Society)|October 28, 2018
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysisConstantinos O'Mahony, Mohammed Majid Akhtar, Zacharias Anastasiou, et al.
Journal of the American College of Cardiology|March 12, 2025
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid CardiomyopathyDaniel P Judge, Kevin M Alexander, Francesco Cappelli, et al.
European Heart Journal|November 6, 2020
Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differencesJob A J Verdonschot, Marco Merlo, Fernando Dominguez, et al.
ACS Sensors|December 12, 2018
Implanted Nanosensors in Marine Organisms for Physiological Biologging: Design, Feasibility, and Species VariabilityMichael A Lee, Freddy T Nguyen, Kathleen Scott, et al.
Acta Obstetricia Et Gynecologica Scandinavica|August 22, 2024
Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trialMarta Ricart, Erika Bonacina, Pablo Garcia-Manau, et al.
Pageof 46